Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

Bullboard Posts

Comment by RalphRalphon Nov 08, 2020 8:46pm

218 Views

Post# 31860357

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Opinion

Obviously Dan isn't going anywhere - I never disputed that. I noticed you had no rebuttal to any of my points; feel free to point out flaws in specific points I've made if you think I'm wrong. I'm not here to love or hate, just to look rationally & objectively at the facts.

MrMugsy wrote: We could go round and round on this topic.
Back to my point - Dan isn't going anywhere until he's ready.
My assumption based on white I know re. the voting.

More importantly is the upcoming negotiations and planning for Phase 3.

Love or Hate all you want - doesn't matter.